GlobeNewswire 2/28/2019 FDA approves Herceptin Hylecta for subcutaneous injection in certain HER2-positive breast cancers
GlobeNewswire 2/25/2019 Roche enters into definitive merger agreement to acquire Spark Therapeutics
GlobeNewswire 2/19/2019 FDA grants Priority Review to Roche's personalised medicine entrectinib
GlobeNewswire 2/19/2019 FDA grants Priority Review to Roche's polatuzumab vedotin in previously treated aggressive lymphoma
GlobeNewswire 2/6/2019 Roche joins the World Federation of Hemophilia Humanitarian Aid Program
GlobeNewswire 2/5/2019 Roche submits supplemental biologics license application to US FDA for Kadcyla for adjuvant treatmen...
GlobeNewswire 2/1/2019 CHMP recommends EU approval of Roche's Hemlibra for people with severe haemophilia A without factor ...
GlobeNewswire 2/1/2019 CHMP recommends EU approval of Roche's Tecentriq in combination with Avastin and chemotherapy as an ...
GlobeNewswire 1/31/2019 Roche reports very strong results in 2018
GlobeNewswire 1/30/2019 Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer's dis...
GlobeNewswire 1/17/2019 FDA accepts Roche's supplemental biologics license application for Tecentriq plus chemotherapy (Abra...
GlobeNewswire 12/17/2018 PRIME designation granted by European Medicines Agency for Roche's risdiplam for treatment of spinal...
GlobeNewswire 12/10/2018 New member proposed for election to Roche Board of Directors
GlobeNewswire 12/10/2018 Changes to the Roche Corporate Executive Committee
GlobeNewswire 12/7/2018 FDA approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatmen...
GlobeNewswire 12/5/2018 Roche's Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-...
GlobeNewswire 12/5/2018 FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial tre...
GlobeNewswire 12/4/2018 New Venclexta/Venclyxto data demonstrate deep responses in two of the most common types of leukaemia
GlobeNewswire 12/3/2018 Roche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children w...
GlobeNewswire 12/3/2018 Longer-term follow-up data demonstrate sustained benefit of polatuzumab vedotin-based treatment in r...
GlobeNewswire 11/21/2018 Roche announces FDA grants Venclexta accelerated approval for people with newly-diagnosed acute myel...
GlobeNewswire 11/13/2018 FDA grants priority review to Roche's Tecentriq in combination with Abraxane for the initial treatme...
GlobeNewswire 11/1/2018 Roche to present new data from its industry-leading haematology portfolio at the American Society of...
GlobeNewswire 11/1/2018 Phase III data showed that Venclexta/Venclyxto plus Gazyva/Gazyvaro reduced the risk of disease wors...
GlobeNewswire 11/1/2018 Roche announces EU approval of Venclyxto plus MabThera for people with previously treated chronic ly...